Cargando…

Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b

Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately faces innate immune reactions such as the activated complement system. Here, a novel innate immune evasion strategy of S. aureus is described. The staphylococcal proteins surface immunoglobulin-binding pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koch, Tina K., Reuter, Michael, Barthel, Diana, Böhm, Sascha, van den Elsen, Jean, Kraiczy, Peter, Zipfel, Peter F., Skerka, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469469/ https://www.ncbi.nlm.nih.gov/pubmed/23071827 http://dx.doi.org/10.1371/journal.pone.0047638

Ejemplares similares

The Staphylococcus aureus Protein Sbi Acts as a Complement Inhibitor and Forms a Tripartite Complex with Host Complement Factor H and C3b
por: Haupt, Katrin, et al.
Publicado: (2008)

Contribution of the Infection-Associated Complement Regulator-Acquiring Surface Protein 4 (ErpC) to Complement Resistance of Borrelia burgdorferi
por: Hammerschmidt, Claudia, et al.
Publicado: (2012)

Borrelia valaisiana Resist Complement-Mediated Killing Independently of the Recruitment of Immune Regulators and Inactivation of Complement Components
por: Schwab, Jasmin, et al.
Publicado: (2013)

Staphylococcal Complement Evasion Protein Sbi Stabilises C3d Dimers by Inducing an N-Terminal Helix Swap
por: Dunphy, Rhys W., et al.
Publicado: (2022)

CspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway
por: Hallström, Teresia, et al.
Publicado: (2013)

Plasmin as a complement C5 convertase
por: Leung, Lawrence L., et al.
Publicado: (2016)

In situ Visualization of C3/C5 Convertases to Differentiate Complement Activation
por: Person, Fermin, et al.
Publicado: (2020)

A structural basis for Staphylococcal complement subversion: X-ray structure of the complement-binding domain of Staphylococcus aureus protein Sbi in complex with ligand C3d
por: Clark, Elizabeth A., et al.
Publicado: (2011)

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases
por: Zhao, Fei, et al.
Publicado: (2019)

Structure-Function Analysis of the C3 Binding Region of Staphylococcus aureus Immune Subversion Protein Sbi
por: Upadhyay, Abhishek, et al.
Publicado: (2008)

Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif
por: Hallström, Teresia, et al.
Publicado: (2016)

The Complement Binding and Inhibitory Protein CbiA of Borrelia miyamotoi Degrades Extracellular Matrix Components by Interacting with Plasmin(ogen)
por: Nguyen, Ngoc T. T., et al.
Publicado: (2018)

THE INACTIVATION OF COMPLEMENT AND ITS COMPONENTS BY PLASMIN
por: Pillemer, Louis, et al.
Publicado: (1953)

A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTOR
por: Ward, Peter A.
Publicado: (1967)

Complement catalyzing glomerular diseases
por: Zipfel, Peter F., et al.
Publicado: (2021)

Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
por: Siegel, Corinna, et al.
Publicado: (2010)

Deciphering the Ligand-binding Sites in the Borrelia burgdorferi Complement Regulator-acquiring Surface Protein 2 Required for Interactions with the Human Immune Regulators Factor H and Factor H-like Protein 1
por: Siegel, Corinna, et al.
Publicado: (2008)

Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation
por: Eberhardt, Hannes U., et al.
Publicado: (2013)

Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin
por: Foley, Jonathan H., et al.
Publicado: (2016)

Complement Inhibitors in Clinical Trials for Glomerular Diseases
por: Zipfel, Peter F., et al.
Publicado: (2019)

Further structural insights into the binding of complement factor H by complement regulator-acquiring surface protein 1 (CspA) of Borrelia burgdorferi
por: Caesar, Joseph J. E., et al.
Publicado: (2013)

24th European Conference on Few-Body Problems in Physics (EFB)
por: Collective
Publicado: (2019)

THE CONVERSION OF C'1S TO C'1 ESTERASE BY PLASMIN AND TRYPSIN
por: Ratnoff, Oscar D., et al.
Publicado: (1967)

Coagulase and Efb of Staphylococcus aureus Have a Common Fibrinogen Binding Motif
por: Ko, Ya-Ping, et al.
Publicado: (2016)

Extracellular Xylanopectinolytic Enzymes by Bacillus subtilis ADI1 from EFB's Compost
por: Nawawi, Muhammad Hariadi, et al.
Publicado: (2017)

Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium)
por: Barbosa, Carolina, et al.
Publicado: (2015)

THE INFLUENCE OF CALCIUM IONS ON THE INACTIVATION OF HUMAN COMPLEMENT AND ITS COMPONENTS BY PLASMIN
por: Lepow, Irwin H., et al.
Publicado: (1953)

Staphylococcus pseudintermedius Sbi paralogs inhibit complement and bind IgM, IgG Fc and Fab
por: Sewid, Alaa H., et al.
Publicado: (2019)

Novel method for detecting complement C3 deposition on Staphylococcus aureus
por: Wonfor, Toska, et al.
Publicado: (2022)

Bacillus anthracis Interacts with Plasmin(ogen) to Evade C3b-Dependent Innate Immunity
por: Chung, Myung-Chul, et al.
Publicado: (2011)

THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR
por: Ratnoff, Oscar D., et al.
Publicado: (1969)

Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant
por: Yang, Yi, et al.
Publicado: (2019)

Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases
por: Schäfer, Nicole, et al.
Publicado: (2016)

Hide and Seek: How Lyme Disease Spirochetes Overcome Complement Attack
por: Kraiczy, Peter
Publicado: (2016)

Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack
por: Hallström, Teresia, et al.
Publicado: (2015)

Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway
Publicado: (1976)

Ensilication Improves the Thermal Stability of the Tuberculosis Antigen Ag85b and an Sbi-Ag85b Vaccine Conjugate
por: Wahid, A. A., et al.
Publicado: (2019)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4
por: van Burgel, Nathalie D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jc7baqk7s1lhiglv6m7p2b7c1k